I have created a six-hour biotechnology education series at bit.ly/LfbSdS, and I want to highlight the policy discussion here. It is easy to ignore policy when operating in biotechnology. The importance of an understanding of the business of biotechnology, of patent and other legal issues, and of the science of biotechnology is clear, but it is not […]
January 28, 2014 Comments Off on Are Ribosomal Readthrough Drugs the Next Biotech Magic Bullet? Posted in: General Biotechnology On a recent press tour of New Jersey I was introduced to PTC Therapeutics, a fascinating company that is developing ribosomal readthrough drugs for several indications. What I find so interesting about this company and their technology is that it is a sort of magic bullet. Drugs that can modulate ribosomal activity can potentially treat […]
